CLYM
Climb Bio, Inc. Common Stock
CLYM
CLYM
22 hedge funds and large institutions have $46.8M invested in Climb Bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.
Holders
22
Holders Change
+3
Holders Change %
+15.79%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
BCM
1
BML Capital Management
Zionsville,
Indiana
|
$4.43M |
2 |
2
Morgan Stanley
New York
|
$4.79K |
3 |
3
Millennium Management
New York
|
$182K |
4 |
CPIG
4
Chicago Partners Investment Group
Chicago,
Illinois
|
$45.7K |
5 |
5
BlackRock
New York
|
$89.3K |